STOCK TITAN

[SCHEDULE 13G/A] Semler Scientific, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Semler Scientific (Common Stock, CUSIP 81684M104) is reported as beneficially owned in aggregate by a group of affiliated Susquehanna entities and Capital Ventures International totaling 597,196 shares, equal to 4.4% of the 13,688,405 shares outstanding as of June 30, 2025. The filing states that Susquehanna Securities, LLC includes 202,600 options to acquire shares. Individual reporting persons disclose allocated voting and dispositive powers, with Susquehanna Securities reporting 398,215 sole voting/dispositive shares and Capital Ventures International reporting 181,494 sole voting/dispositive shares; smaller sole holdings are reported for G1 Execution Services and SIG Brokerage.

This Schedule 13G/A (Amendment No. 2) presents a passive-group disclosure: the reporting persons state the holdings were not acquired to influence control. The filing includes issuer and reporting persons' addresses and is signed by Brian Sopinsky on 08/13/2025.

Semler Scientific (Common Stock, CUSIP 81684M104) è segnalata come detenuta in aggregato da un gruppo di entità affiliate di Susquehanna e da Capital Ventures International per un totale di 597,196 azioni, pari al 4.4% delle 13,688,405 azioni in circolazione al 30 giugno 2025. La comunicazione specifica che Susquehanna Securities, LLC include 202,600 opzioni per l'acquisto di azioni. Le persone segnalanti dichiarano poteri di voto e di disposizione allocati: Susquehanna Securities riporta 398,215 azioni con potere di voto/dispositivo esclusivo e Capital Ventures International riporta 181,494 azioni con potere di voto/dispositivo esclusivo; partecipazioni minori in esclusiva sono indicate per G1 Execution Services e SIG Brokerage.

Questo Schedule 13G/A (Emendamento n. 2) contiene una dichiarazione di gruppo passivo: le persone segnalanti affermano che le partecipazioni non sono state acquisite per influenzare il controllo. Il deposito include gli indirizzi dell'emittente e delle persone segnalanti ed è firmato da Brian Sopinsky in data 08/13/2025.

Semler Scientific (Common Stock, CUSIP 81684M104) se informa como propiedad beneficiaria en conjunto de un grupo de entidades afiliadas de Susquehanna y de Capital Ventures International por un total de 597,196 acciones, equivalentes al 4.4% de las 13,688,405 acciones en circulación a fecha del 30 de junio de 2025. La presentación indica que Susquehanna Securities, LLC incluye 202,600 opciones para adquirir acciones. Las personas informantes declaran poderes de voto y dispositivos asignados: Susquehanna Securities informa 398,215 acciones con voto/disposición exclusivo y Capital Ventures International informa 181,494 acciones con voto/disposición exclusivo; se reportan tenencias exclusivas menores para G1 Execution Services y SIG Brokerage.

Este Schedule 13G/A (Enmienda n.º 2) presenta una divulgación de grupo pasivo: los informantes declaran que las participaciones no fueron adquiridas para influir en el control. La presentación incluye las direcciones del emisor y de los informantes y está firmada por Brian Sopinsky el 08/13/2025.

Semler Scientific (Common Stock, CUSIP 81684M104)는 Susquehanna 계열사들과 Capital Ventures International으로 구성된 그룹이 총 597,196주를 보유하고 있는 것으로 집단적으로 보고되었으며, 이는 2025년 6월 30일 기준 유통주식 13,688,405주의 4.4%에 해당합니다. 제출 문서에는 Susquehanna Securities, LLC202,600주의 주식 취득 옵션을 포함하고 있다고 명시되어 있습니다. 보고인들은 배분된 의결권 및 처분권을 공개했으며, Susquehanna Securities398,215주의 단독 의결/처분권을, Capital Ventures International181,494주의 단독 의결/처분권을 보고했습니다. G1 Execution Services 및 SIG Brokerage는 소규모 단독 보유를 보고했습니다.

이 Schedule 13G/A (Amendment No. 2)는 수동 그룹 공개에 관한 것으로, 보고인들은 보유 지분이 경영권에 영향을 미치기 위해 취득된 것이 아니라고 명시했습니다. 제출 서류에는 발행인 및 보고인의 주소가 포함되어 있으며 08/13/2025에 Brian Sopinsky가 서명했습니다.

Semler Scientific (Common Stock, CUSIP 81684M104) est signalée comme étant détenue à titre bénéficiaire, au total, par un groupe d'entités affiliées à Susquehanna et par Capital Ventures International pour un total de 597,196 actions, soit 4.4% des 13,688,405 actions en circulation au 30 juin 2025. Le dépôt indique que Susquehanna Securities, LLC comprend 202,600 options d'acquérir des actions. Les déclarants divulguent des pouvoirs de vote et de disposition alloués : Susquehanna Securities déclare 398,215 actions avec pouvoir de vote/disposition exclusif et Capital Ventures International déclare 181,494 actions avec pouvoir de vote/disposition exclusif ; des participations exclusives plus faibles sont signalées pour G1 Execution Services et SIG Brokerage.

Ce Schedule 13G/A (Amendement n°2) présente une divulgation de groupe passif : les déclarants indiquent que les participations n'ont pas été acquises en vue d'influencer le contrôle. Le dépôt inclut les adresses de l'émetteur et des déclarants et est signé par Brian Sopinsky le 08/13/2025.

Semler Scientific (Common Stock, CUSIP 81684M104) wird als wirtschaftlich gehalten gemeldet — zusammen von einer Gruppe verbundener Susquehanna-Einheiten und Capital Ventures International — in Höhe von insgesamt 597,196 Aktien, entsprechend 4.4% der 13,688,405 ausstehenden Aktien zum 30. Juni 2025. Die Einreichung gibt an, dass Susquehanna Securities, LLC 202,600 Optionen zum Erwerb von Aktien umfasst. Die meldenden Personen geben zugeteilte Stimm- und Verfügungsbefugnisse an: Susquehanna Securities meldet 398,215 Aktien mit alleinigem Stimm-/Verfügungsrecht und Capital Ventures International meldet 181,494 Aktien mit alleinigem Stimm-/Verfügungsrecht; kleinere Alleinbestände werden für G1 Execution Services und SIG Brokerage ausgewiesen.

Dieses Schedule 13G/A (Amendment Nr. 2) enthält eine Offenlegung als passive Gruppe: die meldenden Personen erklären, dass die Bestände nicht erworben wurden, um die Kontrolle zu beeinflussen. Die Einreichung enthält die Adressen des Emittenten und der meldenden Personen und ist von Brian Sopinsky am 08/13/2025 unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Group holds 597,196 shares (4.4%), passive disclosure; options increase potential economic exposure.

The filing documents a 4.4% aggregated stake in Semler Scientific (13,688,405 shares outstanding), with 202,600 options included in Susquehanna Securities' reported position. From a capital-markets perspective, the size is meaningful enough to warrant monitoring but remains below common 5% materiality thresholds for larger signaling events. The report clarifies which entities hold sole versus shared voting and dispositive power, which helps analysts understand governance influence and potential voting outcomes on routine matters.

TL;DR: Reporting clarifies allocation of voting/dispositive power across affiliated entities and confirms passive intent.

The submission lays out a formal group filing among Susquehanna affiliates and Capital Ventures International, including a disclaimer that each reporting person disclaims ownership of shares held by others and that Susquehanna Advisors Group, Inc. may exercise voting/dispositive power for Capital Ventures International as investment manager. This allocation is important for shareholder meeting mechanics because it specifies which entities report sole control and which report shared control, while the certification states the holdings were not acquired to change issuer control.

Semler Scientific (Common Stock, CUSIP 81684M104) è segnalata come detenuta in aggregato da un gruppo di entità affiliate di Susquehanna e da Capital Ventures International per un totale di 597,196 azioni, pari al 4.4% delle 13,688,405 azioni in circolazione al 30 giugno 2025. La comunicazione specifica che Susquehanna Securities, LLC include 202,600 opzioni per l'acquisto di azioni. Le persone segnalanti dichiarano poteri di voto e di disposizione allocati: Susquehanna Securities riporta 398,215 azioni con potere di voto/dispositivo esclusivo e Capital Ventures International riporta 181,494 azioni con potere di voto/dispositivo esclusivo; partecipazioni minori in esclusiva sono indicate per G1 Execution Services e SIG Brokerage.

Questo Schedule 13G/A (Emendamento n. 2) contiene una dichiarazione di gruppo passivo: le persone segnalanti affermano che le partecipazioni non sono state acquisite per influenzare il controllo. Il deposito include gli indirizzi dell'emittente e delle persone segnalanti ed è firmato da Brian Sopinsky in data 08/13/2025.

Semler Scientific (Common Stock, CUSIP 81684M104) se informa como propiedad beneficiaria en conjunto de un grupo de entidades afiliadas de Susquehanna y de Capital Ventures International por un total de 597,196 acciones, equivalentes al 4.4% de las 13,688,405 acciones en circulación a fecha del 30 de junio de 2025. La presentación indica que Susquehanna Securities, LLC incluye 202,600 opciones para adquirir acciones. Las personas informantes declaran poderes de voto y dispositivos asignados: Susquehanna Securities informa 398,215 acciones con voto/disposición exclusivo y Capital Ventures International informa 181,494 acciones con voto/disposición exclusivo; se reportan tenencias exclusivas menores para G1 Execution Services y SIG Brokerage.

Este Schedule 13G/A (Enmienda n.º 2) presenta una divulgación de grupo pasivo: los informantes declaran que las participaciones no fueron adquiridas para influir en el control. La presentación incluye las direcciones del emisor y de los informantes y está firmada por Brian Sopinsky el 08/13/2025.

Semler Scientific (Common Stock, CUSIP 81684M104)는 Susquehanna 계열사들과 Capital Ventures International으로 구성된 그룹이 총 597,196주를 보유하고 있는 것으로 집단적으로 보고되었으며, 이는 2025년 6월 30일 기준 유통주식 13,688,405주의 4.4%에 해당합니다. 제출 문서에는 Susquehanna Securities, LLC202,600주의 주식 취득 옵션을 포함하고 있다고 명시되어 있습니다. 보고인들은 배분된 의결권 및 처분권을 공개했으며, Susquehanna Securities398,215주의 단독 의결/처분권을, Capital Ventures International181,494주의 단독 의결/처분권을 보고했습니다. G1 Execution Services 및 SIG Brokerage는 소규모 단독 보유를 보고했습니다.

이 Schedule 13G/A (Amendment No. 2)는 수동 그룹 공개에 관한 것으로, 보고인들은 보유 지분이 경영권에 영향을 미치기 위해 취득된 것이 아니라고 명시했습니다. 제출 서류에는 발행인 및 보고인의 주소가 포함되어 있으며 08/13/2025에 Brian Sopinsky가 서명했습니다.

Semler Scientific (Common Stock, CUSIP 81684M104) est signalée comme étant détenue à titre bénéficiaire, au total, par un groupe d'entités affiliées à Susquehanna et par Capital Ventures International pour un total de 597,196 actions, soit 4.4% des 13,688,405 actions en circulation au 30 juin 2025. Le dépôt indique que Susquehanna Securities, LLC comprend 202,600 options d'acquérir des actions. Les déclarants divulguent des pouvoirs de vote et de disposition alloués : Susquehanna Securities déclare 398,215 actions avec pouvoir de vote/disposition exclusif et Capital Ventures International déclare 181,494 actions avec pouvoir de vote/disposition exclusif ; des participations exclusives plus faibles sont signalées pour G1 Execution Services et SIG Brokerage.

Ce Schedule 13G/A (Amendement n°2) présente une divulgation de groupe passif : les déclarants indiquent que les participations n'ont pas été acquises en vue d'influencer le contrôle. Le dépôt inclut les adresses de l'émetteur et des déclarants et est signé par Brian Sopinsky le 08/13/2025.

Semler Scientific (Common Stock, CUSIP 81684M104) wird als wirtschaftlich gehalten gemeldet — zusammen von einer Gruppe verbundener Susquehanna-Einheiten und Capital Ventures International — in Höhe von insgesamt 597,196 Aktien, entsprechend 4.4% der 13,688,405 ausstehenden Aktien zum 30. Juni 2025. Die Einreichung gibt an, dass Susquehanna Securities, LLC 202,600 Optionen zum Erwerb von Aktien umfasst. Die meldenden Personen geben zugeteilte Stimm- und Verfügungsbefugnisse an: Susquehanna Securities meldet 398,215 Aktien mit alleinigem Stimm-/Verfügungsrecht und Capital Ventures International meldet 181,494 Aktien mit alleinigem Stimm-/Verfügungsrecht; kleinere Alleinbestände werden für G1 Execution Services und SIG Brokerage ausgewiesen.

Dieses Schedule 13G/A (Amendment Nr. 2) enthält eine Offenlegung als passive Gruppe: die meldenden Personen erklären, dass die Bestände nicht erworben wurden, um die Kontrolle zu beeinflussen. Die Einreichung enthält die Adressen des Emittenten und der meldenden Personen und ist von Brian Sopinsky am 08/13/2025 unterzeichnet.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 5 through Row 9 above, G1 Execution Services, LLC, SIG Brokerage, LP and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International and Susquehanna Advisors Group, Inc., may be deemed a group. For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons. Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person. With respect to Row 5 and Row 7 above, Susquehanna Advisors Group, Inc. is the investment manager to Capital Ventures International and as such may exercise voting and dispositive power over the shares directly owned by Capital Ventures International.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 5 through Row 9 above, G1 Execution Services, LLC, SIG Brokerage, LP and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International and Susquehanna Advisors Group, Inc., may be deemed a group. For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons. Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person. With respect to Row 5 and Row 7 above, Susquehanna Advisors Group, Inc. is the investment manager to Capital Ventures International and as such may exercise voting and dispositive power over the shares directly owned by Capital Ventures International.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 5 through Row 9 above, G1 Execution Services, LLC, SIG Brokerage, LP and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International and Susquehanna Advisors Group, Inc., may be deemed a group. For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons. Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 5 through Row 9 above, G1 Execution Services, LLC, SIG Brokerage, LP and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International and Susquehanna Advisors Group, Inc., may be deemed a group. For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons. Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 5 through Row 9 above, G1 Execution Services, LLC, SIG Brokerage, LP and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International and Susquehanna Advisors Group, Inc., may be deemed a group. For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons. Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.


SCHEDULE 13G



Capital Ventures International
Signature:/s/ Brian Sopinsky
Name/Title:Brian Sopinsky, Assistant Secretary of Susquehanna Advisors Group, Inc.
Date:08/13/2025
Susquehanna Advisors Group, Inc.
Signature:/s/ Brian Sopinsky
Name/Title:Brian Sopinsky, Assistant Secretary
Date:08/13/2025
G1 Execution Services, LLC
Signature:/s/ Brian Sopinsky
Name/Title:Brian Sopinsky, Secretary
Date:08/13/2025
SIG Brokerage, LP
Signature:/s/ Brian Sopinsky
Name/Title:Brian Sopinsky, Assistant Secretary
Date:08/13/2025
Susquehanna Securities, LLC
Signature:/s/ Brian Sopinsky
Name/Title:Brian Sopinsky, Secretary
Date:08/13/2025

Comments accompanying signature: Susquehanna Advisors Group, Inc. serves as authorized agent of Capital Ventures International pursuant to a Limited Power of Attorney, a copy of which was previously filed.
Exhibit Information

EXHIBIT INDEX EXHIBIT DESCRIPTION ________ ________ 24 Limited Power of Attorney* 99 Joint Filing Agreement * Previously filed

FAQ

What stake does the reporting group hold in Semler Scientific (SMLR)?

The reporting persons collectively disclose ownership of 597,196 shares, representing 4.4% of the 13,688,405 shares outstanding as of June 30, 2025.

Does the filing include any options or derivative holdings for SMLR?

Yes. The filing states that Susquehanna Securities, LLC includes options to buy 202,600 shares in its reported amount.

Who are the reporting persons named in the Schedule 13G/A for SMLR?

The filing is by five reporting persons: Capital Ventures International, Susquehanna Advisors Group, Inc., G1 Execution Services, LLC, SIG Brokerage, LP, and Susquehanna Securities, LLC.

How is voting and dispositive power allocated among the reporting persons?

Allocation per the cover pages: Susquehanna Securities reports 398,215 sole voting/dispositive shares, Capital Ventures International reports 181,494 sole voting/dispositive shares, G1 Execution reports 4,936, and SIG Brokerage reports 12,551; each also reports shared voting/dispositive power over the 597,196 aggregate.

When was the Schedule 13G/A signed and by whom for SMLR?

The signatures are dated 08/13/2025 and signed by /s/ Brian Sopinsky in roles including Assistant Secretary and Secretary for the reporting entities.
Semler Scientific Inc

NASDAQ:SMLR

SMLR Rankings

SMLR Latest News

SMLR Latest SEC Filings

SMLR Stock Data

511.35M
13.03M
12.84%
61.22%
20.27%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
CAMPBELL